Acquisitions: Pharma giants have targeted their acquisitions in order to expand the obesity pipeline
Heat causes individual tirzepatide molecules to unfold slightly, exposing hydrophobic regions that are normally buried inside the folded structure
Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system
This treatment can also reduce water weight gain and help the body breakdown fat and carbohydrates
Gajewski JB and Al-Zahrani AA: The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre
F.RaychaudhuriU.HsuS.BedlackR